Abstract
Plasmid-mediated Quinolone Resistance in<i>Salmonella enterica</i>, United Kingdom
Highlights
The study was carried out within the research activities of the ANTRES project, supported by the European Commission, International Scientific Cooperation Projects for Developing Countries program, Contract ICA4-CT-2001-10014
Since 1998, plasmid-mediated quinolone resistance encoded by qnr genes A, B, and S that confer lowlevel resistance to nalidixic acid and reduced susceptibility to ciprofloxacin has been identified in several enterobacterial species, including Salmonella
We recently reported identification of qnr genes in Salmonella in the United Kingdom [1]
Summary
The study was carried out within the research activities of the ANTRES project, supported by the European Commission, International Scientific Cooperation Projects for Developing Countries program, Contract ICA4-CT-2001-10014. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. High-level fluoroquinolone resistance is uncommon, but reduced susceptibility is increasing. Since 1998, plasmid-mediated quinolone resistance encoded by qnr genes A, B, and S that confer lowlevel resistance to nalidixic acid and reduced susceptibility to ciprofloxacin has been identified in several enterobacterial species, including Salmonella.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
